Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism

Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism

Diabetic patients have a two- to four-fold increase in the risk of heart failure (HF), and the co-existence of diabetes and HF is associated with poor prognosis. In randomized clinical trials (RCTs), compelling evidence has demonstrated the beneficial effects of sodium-glucose co-transporter-2 inhib...

Full description

Bibliographic Details
Main Authors: Chih-Neng Hsu, Chin-Feng Hsuan, Daniel Liao, Jack Keng-Jui Chang, Allen Jiun-Wei Chang, Siow-Wey Hee, Hsiao-Lin Lee, Sean I. F. Teng
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Life
Subjects:
anti-diabetic therapy
heart failure
randomized clinical trials
molecular mechanism
sodium-glucose co-transporter-2 inhibitors
Online Access:https://www.mdpi.com/2075-1729/13/4/1024

Internet

https://www.mdpi.com/2075-1729/13/4/1024

Similar Items